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Abstract
Background—The failure to consider travel-related diagnoses, the lack of diagnostic capacity 
for specialized laboratory testing, and the declining number of autopsies may affect the diagnosis 
and management of travel-related infections. Pre- and post-mortem pathology can help determine 
causes of illness and death in international travelers.
Methods—We conducted a retrospective review of biopsy and autopsy specimens sent to the 
Infectious Diseases Pathology Branch laboratory (IDPBL) at the Centers for Disease Control and 
Prevention (CDC) for diagnostic testing from 1995 through 2015. Cases were included if the 
specimen submitted for diagnosis was from a traveler with prior international travel during the 
disease incubation period and the cause of illness or death was unknown at the time of specimen 
submission.
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Results—Twenty-one travelers, six (29%) with biopsy specimens and 15 (71%) with autopsy 
specimens, met the inclusion criteria. Among the 15 travelers who underwent autopsies, the most 
common diagnoses were protozoal infections (7 travelers; 47%), including five malaria cases, 
followed by viral infections (6 travelers; 40%).
Conclusions—Biopsy or autopsy specimens can assist in diagnosing infectious diseases in 
travelers, especially from pathogens not endemic in the U.S. CDC’s IDPBL provides a useful 
resource for clinicians considering infectious diseases in returned travelers.
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1. Introduction
International travel has expanded over the past 50 years. In 2012, annual worldwide 
international tourist arrivals exceeded one billion, and arrivals will likely reach 1.8 billion by 
2030 [1]. Travel destinations continue to diversify, with emerging economies accounting for 
approximately 533 million tourist arrivals in 2015 [1]. These trends bring more travelers into 
contact with infectious pathogens, which can have serious individual and public health 
consequences and can contribute to infectious disease spread [2].
Travelers often acquire infections while abroad, most commonly a gastrointestinal or 
systemic febrile illness [3]. However, an etiology to explain the travelers’ symptoms may not 
always be determined in the clinical setting. Ill travelers may require non-routine laboratory 
or pathology services, including special serologies or biopsies, to confirm a diagnosis and 
guide effective treatment and public health interventions. In addition, healthcare providers in 
non-endemic countries may fail to consider travel-related diagnoses such as malaria, leading 
to delays in treatment, or death. Healthcare providers should take detailed travel histories 
and have increased suspicion for travel-related infections, using available diagnostic tests as 
appropriate. Specialized pathological biopsy and autopsy specimen testing provide useful 
information about causes of undetermined illness and death in travelers [4] and can expedite 
appropriate treatment. Published data on the total number of deaths due to infectious 
diseases acquired while traveling abroad is lacking.
We present clinical vignettes and final infectious diseases diagnoses of 21 international 
travelers with either biopsy or autopsy specimens sent to the Infectious Diseases Pathology 
Branch Laboratory (IDPBL) at the Centers for Disease Control and Prevention (CDC) for 
diagnostic assistance of unexplained illnesses and deaths. The IDPBL applies histological, 
immunohistochemical, molecular, microbiologic, and ultrastructural methodologies to 
uncover infectious disease diagnoses on tissue specimens or cultures and is available to 
domestic and international clinicians, hospital systems, and health departments [5].
2. Methods
We conducted a retrospective review of autopsy and biopsy specimens sent to CDC’s IDPBL 
for diagnostic testing from 1995 through 2015. Cases were included if the specimen was 
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from an international traveler, the cause of illness or death was unknown at the time of 
specimen submission, and travel was during the disease incubation period. Clinicians and 
pathologists submitted assorted information extracted from the travelers’ medical record. We 
reviewed all available information and recorded traveler demographics, travel destination, 
travel purpose, reported exposures or behaviors during travel, presumptive clinical 
diagnoses, and clinical course details, including outcome.
3. Results
Twenty-one travelers met the inclusion criteria (Table 1). Median age was 38 years (range 2–
73), 43% were female, and 15 (71%) were U.S. residents. Twelve (57%) contracted their 
illness in Sub-Saharan Africa; other exposure regions included Central America (two 
travelers), South America (two travelers), Asia (one traveler), the Caribbean (one traveler), 
the Middle East (one traveler), North America (one traveler), and Oceania (one traveler). Six 
(29%) had biopsy specimens and 15 (71%) had autopsy specimens sent to the IDPBL.
3.1. Travelers with biopsies
Among the six travelers with biopsy specimens, five had cutaneous specimens and one had 
an open lung biopsy specimen; none died (Table 1).
Traveler 1 (2008)—A 58-year-old female had a scalp lesion biopsied after returning to the 
United States from Belize. Gross examination confirmed myiasis with the botfly Dermatobia 
hominis (Fig. 1A).
Traveler 2 (2011)—U.S. immigration officials detained a 62-year-old female with 
extensive face and upper-extremity skin lesions after returning from an 8-week missionary 
trip to rural Ghana. Tissue Gram stain on skin biopsy specimens sent to the IDPBL yielded 
Gram-positive cocci, and immunohistochemistry (IHC) demonstrated group A streptococci 
among diffuse neutrophilic infiltrates with epithelial necrosis, consistent with impetigo (Fig. 
1B and C).
Traveler 3 (2011)—A 59-year-old male developed fever, myalgia, arthralgia, non-
productive cough, hemoptysis, and dyspnea on exertion after returning from a 1-week trip 
constructing homes in rural Panama. A chest radiograph and computed tomography scan of 
the chest revealed pulmonary lesions with mediastinal and hilar lymphadenopathy; he 
underwent an open lung biopsy. Tissue staining revealed multiple small budding yeasts; in 
conjunction with IHC and polymerase chain reaction (PCR), the IDPBL confirmed acute 
Histoplasma capsulatum pneumonia (Fig. 1D).
Traveler 4 (2012)—A 31-year-old male developed a painful, ulcerated leg lesion and fever 
while traveling in rural Papua New Guinea. An infectious diseases consultant suspected a 
Buruli ulcer caused by Mycobacterium ulcerans. A biopsy sent to IDPBL revealed a tropical 
phagedenic ulcer with necrotizing dermatitis, hemorrhage, edema and thrombosis, including 
a polymicrobial infection with Fusobacterium nucleatum and Treponema vincentii. The 
traveler underwent debridement and took cephalexin for 1 week, with lesion improvement.
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Traveler 5 (2014)—A 39-year-old male sustained an insect bite on his leg that ulcerated a 
few months after returning from Peru. The lesion was biopsied and IHC revealed intra- and 
extracellular basophilic structures at the IDPBL, consistent with New World cutaneous 
leishmaniasis (Fig. 1E and F).
Traveler 6 (2015)—A 65-year-old female complained of headache, fevers, chills, 
myalgias, and an eschar on her left calf, where she recalled a tick bite. She recently returned 
from a 2-week trip to South Africa. Her physician prescribed doxycycline and submitted 
skin biopsy specimens to the IDPBL. IHC demonstrated epidermal ulceration with 
lymphohistiocytic inflammation, and PCR yielded Rickettsia africae, the causal agent of 
African tick bite fever (Fig. 1G and H).
3.2. Travelers with autopsies
Among the 15 travelers who underwent autopsies, the most common diagnoses were 
protozoal (7; 47%) and viral (6; 40%) infections. Ten (67%) traveled to Sub-Saharan Africa 
during their illness incubation periods.
3.2.1. Protozoal infections: malaria—Upon histological examination of multiple 
organs and identification of intraerythrocytic Plasmodium falciparum trophozoite and 
schizont staining patterns by IHC, the IDPBL diagnosed travelers 7–11 with fatal P. 
falciparum malaria.
Travelers 7 and 8 (1996): Two male (unknown ages) Romanian cargo ship workers in Sub-
Saharan Africa died aboard their ship. They had recent port calls in Gabon, Guinea, and 
South Africa. Authorities suspected Ebola due to a concurrent outbreak in Gabon [6].
Traveler 9 (2004): A 36-year-old male cargo ship worker became ill with fever, chills, 
headache, myalgias, sore throat, nausea, vomiting, jaundice, and bloody urine. Clinicians 
suspected Lassa fever due to multiple recent port calls in West Africa (Nigeria, Sierra Leone, 
and Côte d’Ivoire). The traveler died while aboard; authorities detained the ship and crew 
offshore until autopsy results became available [6].
Traveler 10 (2005): A 43-year-old male complained of fever, cough, myalgias, arthralgias, 
and “dark urine” after returning from a 2-week missionary trip to the Central African 
Republic and Côte d’Ivoire. His clinician suspected yellow fever or dengue infection. He did 
not take malaria chemoprophylaxis. He died upon arrival to the hospital [6].
Traveler 11 (2011): A 4-year-old female complained of fever, cough, diarrhea, and vomiting 
while visiting friends and relatives in Uganda. She did not take malaria chemoprophylaxis. 
A physician in Uganda treated her for a bacterial infection and tested her for malaria, but she 
did not receive a confirmed diagnosis or malaria treatment. Her condition worsened and she 
died shortly after arrival in the United States [7]. (Fig. 2A).
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3.2.2. Protozoal infections: other
Traveler 12 (2009): A 30-year-old female Sudanese refugee became ill with acute leukemia 
after arriving in the United States from Kenya. She developed severe cardiac failure 2 
months after receiving a bone marrow transplant and died. Cardiac tissue sent to the IDPBL 
indicated myocarditis with protozoal organisms consistent with Sarcocystis spp, confirmed 
by PCR (Fig. 2B).
Traveler 13 (2011): A 2-year-old male became ill with cough, rhinorrhea, and left 
hemiparesis after returning to the United States from Mexico. Brain imaging suggested 
neurocysticercosis; he received steroids and albendazole, without improvement. He 
developed seizures and died. Microscopic examination of brain biopsy specimens sent to the 
IDPBL revealed granulomatous inflammation with necrosis and amebic organisms 
highlighted with IHC (Fig. 2C and D). PCR confirmed infection with Balamuthia 
mandrillaris, a free-living ameba causing granulomatous amebic encephalitis.
3.2.3. Viral infections
Traveler 14 (1999): A 45-year-old male became ill after returning to the United States from 
a 10-day trip to Venezuela, where he swam in fresh water and visited the rainforest. He 
developed fulminant renal and liver failure and disseminated intravascular coagulation, 
complicated by an intracerebral hemorrhage, and died a few days after admission. Autopsy 
specimens sent to the IDPBL showed histopathologic changes with massive hepatocellular 
necrosis, and IHC confirmed the etiologic agent as yellow fever virus.
Traveler 15 (2004): A 38-year-old male Liberian-born U.S. resident became ill with fever, 
chills, sore throat, diarrhea, and back pain while visiting farms in Liberia and Sierra Leone. 
After returning to the United States, he clinically deteriorated with acute respiratory distress 
syndrome despite treatment for malaria and typhoid fever. IHC on liver biopsy specimens 
performed by the IDPBL were positive for Lassa virus. The result was further confirmed by 
serum antigen detection, virus isolation in cell culture, and virus identification by PCR on 
blood, liver, and skin specimens [8] (Fig. 2E and F).
Traveler 16 (2008): A 33-year-old Zambian male paramedic cared for a 36-year-old woman 
on a medical evacuation flight from Zambia to South Africa. The woman had a rash, facial 
swelling, and myalgia and received mechanical ventilation during the flight. The paramedic 
developed headache, myalgia, and fever six days after the flight and died. Blood, liver, and 
skin specimens underwent IHC testing, demonstrating scattered hepatocellular necrosis, and 
PCR revealed a novel Old World arenavirus, Lujo virus. The paramedic’s infection was one 
of three secondary cases from nosocomial contact with the ill woman [9].
Traveler 17 (2010): A 12-year-old female became ill with headache, fever, nausea, 
vomiting, seizures, and altered mental status after returning to the United States from a 2-
week trip to Manila, Philippines. She did not improve with treatment for bacterial meningitis 
and died. Brain biopsy specimens tested at both the state lab and IDPBL demonstrated 
meningoencephalitis with neuronal necrosis, neuronophagia, and glial nodules; PCR 
indicated infection with Japanese encephalitis virus.
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Traveler 18 (2011): A 24-year-old male soldier deployed to Afghanistan sustained a dog 
bite to the right hand. He did not receive rabies post-exposure prophylaxis. He developed 
severe arm pain and right hand paresthesia while en-route to the United States, followed by 
progressive meningoencephalitis and death. Nuchal biopsy specimens, saliva, CSF, and 
autopsy brain samples underwent testing. Microscopic examination of the autopsy brain 
samples demonstrated Negri bodies, and IHC showed rabies viral antigens (Fig. 2 G–H). 
PCR confirmed rabies [10].
Traveler 19 (2011): A 73-year-old Haitian female developed right shoulder pain, headaches, 
and difficulty swallowing while visiting friends and relatives in the United States; she 
developed encephalitis and died. A nuchal skin biopsy sent to the CDC rabies laboratory 
demonstrated rabies antigens by direct fluorescent antibody testing, and a saliva specimen 
tested positive by PCR for rabies virus. Autopsy brain samples submitted to IDPBL showed 
Negri bodies, and IHC was positive for rabies virus. A dog bit the traveler in Haiti and she 
did not receive post-exposure prophylaxis [11].
3.2.4. Rickettsial infections
Traveler 20 (1995): A 38-year-old Swiss female nurse caring for ill prison inmates in 
Burundi developed fever, chills, and myalgias associated with severe thrombocytopenia. She 
received ciprofloxacin for presumed typhoid fever. Despite treatment, she died. 
Histopathologic examination of autopsy specimens sent to the IDPBL demonstrated 
vasculitis in multiple organs, and IHC was positive for typhus group rickettsiae. PCR further 
identified Rickettsia prowazekii, the causative agent of louse-borne epidemic typhus [12].
Traveler 21 (1999): A 39-year old female developed a furuncle on her left leg associated 
with fever, chills, myalgias, headache, and a generalized maculopapular rash while on a 
missionary trip in Kenya. Prior to her illness, her dog had “tick-borne fever” and improved. 
Despite receiving malaria treatment, her condition worsened. She developed a left leg 
eschar, in addition to thrombocytopenia (107,000/mm3), and died. Microscopic examination 
of autopsy tissues showed vasculitis and microthrombi in multiple organs; IHC was positive 
for rickettsiae, but did not identify a species [13].
4. Discussion
We describe the pathologic diagnoses of travel-related illnesses using specialized diagnostic 
capacity from CDC’s IDPBL. These findings illustrate the importance of pathology 
diagnostics in identifying undiagnosed illness or death from infectious diseases. This is 
particularly important for the rising numbers of international travelers who may become ill 
with infections rare or non-endemic in the United States. It is also important for travel 
medicine clinicians who provide care to returned travelers, to utilize these resources for 
appropriate diagnosis and treatment.
Obtaining an autopsy from undiagnosed deceased individuals can provide useful information 
not only about causes of death in travelers, but also on illnesses not recognized clinically 
prior to death [4,14]. For example, an autopsy was recently instrumental in diagnosing the 
first measles death in the United States in 12 years [15]. Autopsies may decrease gaps in 
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surveillance, leading to enhanced infectious disease risk estimates, and result in more rapid 
diagnosis and treatment of contacts, as well as public health response. Despite the autopsy’s 
value for determining cause of death, autopsy rates in the United States have declined 
significantly since the 1960s [4]. Prior to 1970, 40–60% of all hospital deaths in the United 
States received autopsies, but in recent years, decreased to approximately 5% [16]. 
Additionally, infectious diseases accounted for 46% of causes of death determined by 
autopsy in 2007, down from 79% in 1972 [14]. This may be due to improvement in 
infectious disease treatment, but also the relative decrease in medical autopsies and the 
relative increase in autopsies due to external causes (e.g., firearms) [14]. This decline may 
also be due to cost constraints, clinicians seeking fewer autopsies, and the removal of the 
minimum autopsy rate mandate for hospitals by the Joint Commission on Accreditation for 
Healthcare Organizations in 1970 [17]. The declining number of medical autopsies has 
additional effects, such as a decrease in forensic autopsy experience for training 
pathologists, resulting in a lack of experience to recognize subtle findings, or decreased 
medical care quality assurance [17].
Among the 15 deaths, more than half were preventable through recommended pre-travel 
vaccination or chemoprophylaxis. Almost all deaths were potentially preventable through 
early diagnosis and treatment, including the five in travelers infected with P. falciparum 
malaria. The focus on alternative diagnoses, despite travel to a malaria-endemic area, 
resulted in diagnostic and treatment delays. Among the more than 1700 reported malaria 
infections among U.S. travelers in 2013, Africa was the most common exposure region, P. 
falciparum comprised the majority of infections, and there were 10 deaths [18]. Malaria 
must be on the differential diagnosis for febrile travelers with recent travel to a malaria-
endemic country, and such travelers should visit a healthcare professional immediately if any 
malaria symptoms, such as fever, develop during or after travel.
It is imperative to obtain a travel history on all patients, especially those with a fever [3]. 
Clinicians should also note possible risky exposures (e.g., animal, water, or insect 
exposures) in a travelers’ itinerary. Rash was present in only 26%, and an eschar was present 
in 55% of U.S. travelers with spotted fever rickettsioses in one report [19], so reliance on the 
clinical examination and laboratories alone may not always result in a diagnosis.
This report provides details on pathology submissions sent the IDPBL for specialized testing 
that were shown to be travel-related; however, although only one case each of leishmaniasis 
and African tick bite fever are presented, the IDPBL received many traveler’s skin biopsy 
specimens from clinicians concerned about these two diseases. The IDPBL identified 
Leishmania spp. in 370 of these biopsy specimens (CDC data, unpublished). Due to low 
sensitivity and specificity, serologic testing does not play a role in diagnosis; PCR or 
specialized tissue diagnostics are necessary. IDPBL also identified Rickettsia africae in 16 
cutaneous biopsy specimens during the same timeframe; African tick bite fever is the most 
common rickettsiosis identified in travelers returning from Africa [19].
One potential limitation is that the clinical data submitted to the IDPBL for each traveler 
varied. Although we reviewed all available information and recorded traveler demographics, 
travel destination, travel purpose, reported exposures or behaviors during travel, presumptive 
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clinical diagnoses, and clinical course details, including outcome, this information may not 
have been available for all travelers. Efforts are forthcoming to standardize the clinical 
information sent with submitted specimens. An additional limitation is that clinicians may 
opt to submit specimens to the IDPBL based upon the lack of availability of diagnostic 
testing in their institutions or health departments, and the frequency of submission may vary 
by the type of clinical site (and their specialization) or country.
CDC is committed to promoting pathogen detection through laboratory-based diagnostics, 
modern point-of-care testing, and facilitation of specimen submission to public health 
reference laboratories [20]. Access to appropriate diagnostic tests may expedite diagnosis 
and treatment of travelers with infectious diseases. CDC’s IDPBL has the capability to 
perform specialized diagnostic testing to help diagnose unexplained deaths among 
international travelers, and providers are encouraged to use this service 
(pathology@cdc.gov) when encountering difficult cases.
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Fig. 1. 
Histopathologic findings of biopsy and autopsy specimens from international travelers 
submitted to the Centers for Disease Control and Prevention’s Infectious Diseases Pathology 
Branch laboratory, 1995–2015. A) Traveler 1: Dermatobia hominis myiasis. Microscopic 
examination demonstrating the cuticle, striated muscles, and spiracles of the larva; H & E 
staining, original magnification: ×200. B–C) Traveler 2: Group A Streptococcus impetigo. 
B) Skin biopsy demonstrates epidermal ulceration and neutrophilic infiltrate in dermis; H & 
E staining, original magnification: ×200. C) Numerous gram-positive cocci in the dermis 
admixed with neutrophils; Lillie-Twort Gram staining, original magnification: ×400. D) 
Traveler 3: Acute pulmonary histoplasmosis. Lung biopsy demonstrating necrotizing 
inflammation with multiple yeast organisms, some with budding feature; Grocott’s 
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methenamine-silver staining, original magnification: ×400. E–F) Traveler 5: Cutaneous 
leishmaniasis. E) Skin biopsy demonstrates lymphohistiocytic infiltrates in dermis with 
abundant intra- and extracellular round basophilic structures; H & E staining, original 
magnification: ×400. F) Immunostaining of Leishmania species in dermis; immunoalkaline 
phosphate staining, naphthol fast red substrate with light hematoxylin counterstain, original 
magnification: ×400. G–H) Traveler 6: African tick-bite fever. G) Skin biopsy demonstrates 
leukocytoclastic vasculitis and perivascular lymphohistiocytic infiltrate; H & E staining, 
original magnification: ×200. H) Immunostaining of spotted fever group rickettsiae in the 
vascular wall and perivascular infiltrates; immunoalkaline phosphate staining, naphthol fast 
red substrate with light hematoxylin counterstain, original magnification: ×400.
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Fig. 2. 
Histopathologic findings of biopsy and autopsy specimens from international travelers 
submitted to the Centers for Disease Control and Prevention’s Infectious Diseases Pathology 
Branch laboratory, 1995–2015. A) Traveler 11: Plasmodium falciparum malaria. 
Microscopic examination demonstrates intraerythrocytic parasites with hemozoin in blood 
vessels of multiple organs; H & E staining, original magnification: ×630. B) Traveler 12: 
Sarcocystosis. Autopsy heart tissue demonstrates numerous Sarcocystis species with 
inflammation and myocyte necrosis; H & E staining, original magnification: ×400. C–D) 
Balamuthia mandrillaris granulomatous amebic encephalitis. C) Autopsy brain tissue 
demonstrates granulomatous inflammation and vascular necrosis with many amebic 
organisms around the vessel; H & E staining, original magnification: ×400. D) 
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Immunostaining of many Balamuthia mandrillaris in the brain; immunoalkaline phosphate 
staining, naphthol fast red substrate with light hematoxylin counterstain, original 
magnification: ×400. E-F) Traveler 15: Lassa fever. E) Autopsy liver tissue demonstrates 
multifocal hepatocellular necrosis, H & E staining, original magnification: ×200. F) 
Immunostaining of abundant Lassa virus antigens in the liver; immunoalkaline phosphate 
staining, naphthol fast red substrate with light hematoxylin counterstain, original 
magnification: ×200. G–H) Traveler 18: Rabies. G) Autopsy brain tissue demonstrates 
meningoencephalitis with viral inclusions (Negri bodies) in cerebellar Purkinje cells; H & E 
staining, original magnification: ×400. H) Immunostaining of rabies virus antigens in the 
brain; immunoalkaline phosphate staining, naphthol fast red substrate with light hematoxylin 
counterstain, original magnification: ×200.
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